Pan-cancer analysis of osteogenesis imperfecta causing gene SERPINF1
Intractable & Rare Diseases Research · 28.02.2022 · 11 (1) · 15-24
DOI: 10.5582/irdr.2021.01138 ↗Kurz gefasst
Fachartikel in der Zeitschrift Intractable & Rare Diseases Research, erschienen am 28.02.2022. Verfasst von Chao Zhang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences…. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Key Laboratory for Biotech-Drugs of National Health Commission, Key Laboratory for Rare & Uncommon Diseases of Shandong Province, Biomedical Sciences College & Shandong Medicinal Biotechnology Centre, Shandong First Med…
Zitieren
APA
Zhang, C., Yang, W., Zhang, S., Zhang, Y., Liu, P., Li, X., Zhi, W., Yang, D., Li, M., & Lu, Y. (2022). Pan-cancer analysis of osteogenesis imperfecta causing gene SERPINF1. Intractable & Rare Diseases Research, 11(1), 15-24. https://doi.org/10.5582/irdr.2021.01138
Vancouver
Zhang C, Yang W, Zhang S, Zhang Y, Liu P, Li X, et al. Pan-cancer analysis of osteogenesis imperfecta causing gene SERPINF1. Intractable & Rare Diseases Research. 2022;11(1):15-24. doi:10.5582/irdr.2021.01138
BibTeX
@article{Zhang2022,
author = {Zhang, Chao and Yang, Wei and Zhang, Shanshan and Zhang, Yongtao and Liu, Pengchao and Li, Xianxian and Zhi, Wei and Yang, Dan and Li, Mian and Lu, Yanqin},
title = {Pan-cancer analysis of osteogenesis imperfecta causing gene SERPINF1},
journal = {Intractable & Rare Diseases Research},
year = {2022},
volume = {11},
number = {1},
pages = {15--24},
doi = {10.5582/irdr.2021.01138}
}
EUVIMED